163 related articles for article (PubMed ID: 22813425)
1. Vitamin A deficiency disrupts vaccine-induced antibody-forming cells and the balance of IgA/IgG isotypes in the upper and lower respiratory tract.
Surman SL; Rudraraju R; Sealy R; Jones B; Hurwitz JL
Viral Immunol; 2012 Aug; 25(4):341-4. PubMed ID: 22813425
[TBL] [Abstract][Full Text] [Related]
2. Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.
Sealy R; Jones BG; Surman SL; Hurwitz JL
Vaccine; 2010 Sep; 28(41):6749-56. PubMed ID: 20682364
[TBL] [Abstract][Full Text] [Related]
3. Reduced frequencies and heightened CD103 expression among virus-induced CD8(+) T cells in the respiratory tract airways of vitamin A-deficient mice.
Rudraraju R; Surman SL; Jones BG; Sealy R; Woodland DL; Hurwitz JL
Clin Vaccine Immunol; 2012 May; 19(5):757-65. PubMed ID: 22398245
[TBL] [Abstract][Full Text] [Related]
4. Oral retinyl palmitate or retinoic acid corrects mucosal IgA responses toward an intranasal influenza virus vaccine in vitamin A deficient mice.
Surman SL; Jones BG; Sealy RE; Rudraraju R; Hurwitz JL
Vaccine; 2014 May; 32(22):2521-4. PubMed ID: 24657715
[TBL] [Abstract][Full Text] [Related]
5. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
[TBL] [Abstract][Full Text] [Related]
6. Matching antibody class with pathogen type and portal of entry: cognate mechanisms regulate local isotype expression patterns in lymph nodes draining the respiratory tract of mice inoculated with respiratory viruses, according to virus replication competence and site of inoculation.
Sangster MY; Mo XY; Sealy R; Coleclough C
J Immunol; 1997 Aug; 159(4):1893-902. PubMed ID: 9257854
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens.
Sealy R; Surman S; Hurwitz JL; Coleclough C
Immunology; 2003 Apr; 108(4):431-9. PubMed ID: 12667204
[TBL] [Abstract][Full Text] [Related]
8. Differential localization and function of antibody-forming cells responsive to inactivated or live-attenuated influenza virus vaccines.
Sealy R; Webby RJ; Crumpton JC; Hurwitz JL
Int Immunol; 2013 Mar; 25(3):183-95. PubMed ID: 23143476
[TBL] [Abstract][Full Text] [Related]
9. Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.
Asanuma H; Hirokawa K; Uchiyama M; Suzuki Y; Aizawa C; Kurata T; Sata T; Tamura S
Vaccine; 2001 Jul; 19(28-29):3981-9. PubMed ID: 11427274
[TBL] [Abstract][Full Text] [Related]
10. Phenotypes and functions of persistent Sendai virus-induced antibody forming cells and CD8+ T cells in diffuse nasal-associated lymphoid tissue typify lymphocyte responses of the gut.
Rudraraju R; Surman S; Jones B; Sealy R; Woodland DL; Hurwitz JL
Virology; 2011 Feb; 410(2):429-436. PubMed ID: 21227475
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
[TBL] [Abstract][Full Text] [Related]
12. B cell response to herpesvirus infection of the olfactory neuroepithelium.
Tan CS; Stevenson PG
J Virol; 2014 Dec; 88(24):14030-9. PubMed ID: 25253348
[TBL] [Abstract][Full Text] [Related]
13. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses.
Takao SI; Kiyotani K; Sakaguchi T; Fujii Y; Seno M; Yoshida T
J Virol; 1997 Jan; 71(1):832-8. PubMed ID: 8985426
[TBL] [Abstract][Full Text] [Related]
15. Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.
Burke CW; Li M; Hurwitz JL; Vogel P; Russell CJ
J Virol; 2015 Apr; 89(7):3568-83. PubMed ID: 25589649
[TBL] [Abstract][Full Text] [Related]
16. Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
Shibuya M; Tamiya S; Kawai A; Yoshioka Y
Biochem Biophys Res Commun; 2021 May; 554():166-172. PubMed ID: 33798943
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific IgA response of NALT and cervical lymph node cells in antigen-primed rats.
Asakura K; Saito H; Hata M; Kataura A
Acta Otolaryngol; 1998 Nov; 118(6):859-63. PubMed ID: 9870634
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens.
Shim DH; Ko HJ; Volker G; Potter AA; Mutwiri G; Babiuk LA; Kweon MN
Vaccine; 2010 Mar; 28(11):2311-7. PubMed ID: 20060944
[TBL] [Abstract][Full Text] [Related]
20. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
